 Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization EUA for ensovibep, a DARPin antiviral therapeutic candidate to treat COVID-19. Get the Inside Access Traders Are Using to Profit More and Win Bigger. 